SRAX

SRAX · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

Key indicators

SRAX profitability and balance sheet ratios

EPS -$0.2083 in Jun 2023, against -$0.8775 a year earlier.

EPS by quarter
PeriodEPS
Q3 FY21-$0.153
Q4 FY21-$0.5407
Q1 FY22$0.1322
Q2 FY22-$0.8775
Q3 FY22-$0.145
Q4 FY22-$0.323
Mar 2023$0.0738
Jun 2023-$0.2083

Where the money went

Q4 FY22, from revenue to net income

SRAX brought in $7.3M of revenue in Q4 FY22, −5.4% on a year earlier. It made a net loss of $8.5M.

Revenue
$7.3M
Costs, expenses and taxes
$15.8M
Net income
−$8.5M
Net margin
-116.2%

Income statement

Revenue and profit by reporting period

Revenue
Net income
SRAX income statement, quarterly
Line itemQ2 FY22Q3 FY22Q4 FY22
Revenue$7.7M$5.3M$7.3M
Gross profit$3.8M$4.4M$7.1M
Operating income$0.4M$0.9M−$7.6M
Net income−$23.0M−$3.8M−$8.5M
Diluted EPS-$0.88-$0.14-$0.35

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
SRAX balance sheet, quarterly
Line itemSep 2022Dec 2022Mar 2023
Total assets$30.6M$18.1M$14.5M
Total liabilities$31.4M$27.3M$19.8M
Shareholder equity−$0.8M−$9.2M−$5.3M
Cash and short-term investments$3.3M$8.0M$8.2M
Total debt$2.1M$7.8M$7.8M

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
SRAX cash flow, quarterly
Line itemQ2 FY22Q3 FY22Q4 FY22
Operating cash flow−$1.9M−$1.4M−$3.6M
Investing cash flow$2.3M$0.7M$1.9M
Financing cash flow−$0.5M$0.6M$1.6M
Capital expenditure−$0.1M$0.0M−$0.1M
Free cash flow−$2.0M−$1.4M−$3.7M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.